EMAIL THIS PAGE TO A FRIEND

Bioorganic & medicinal chemistry letters

Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors.


PMID 19541481

Abstract

The N,N'-disubstituted cyanoguanidine is an excellent bioisostere of the thiourea and ketene aminal functional groups. We report the design and synthesis of a novel class of cyanoguanidine-based lactam derivatives as potent and orally active FXa inhibitors. The SAR studies led to the discovery of compound 4 (BMS-269223, K(i)=6.5nM, EC(2xPT)=32muM) as a selective, orally bioavailable FXa inhibitor with an excellent in vitro liability profile, favorable pharmacokinetics and pharmacodynamics in animal models. The X-ray crystal structure of 4 bound in FXa is presented and key ligand-protein interactions are discussed.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

525588
5-Amino-2-methylindole, 97%
C9H10N2
D76609
Dicyandiamide, 99%
C2H4N4